1. Home
  2. CCCC vs LND Comparison

CCCC vs LND Comparison

Compare CCCC & LND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$3.70

Market Cap

404.7M

Sector

Health Care

ML Signal

HOLD

Logo Brasilagro Brazilian Agric Real Estate Co Sponsored ADR (Brazil)

LND

Brasilagro Brazilian Agric Real Estate Co Sponsored ADR (Brazil)

HOLD

Current Price

$3.72

Market Cap

355.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCCC
LND
Founded
2015
2005
Country
United States
Brazil
Employees
N/A
457
Industry
Biotechnology: Pharmaceutical Preparations
Farming/Seeds/Milling
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
404.7M
355.6M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
CCCC
LND
Price
$3.70
$3.72
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$12.20
N/A
AVG Volume (30 Days)
4.0M
47.4K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
3.18%
EPS Growth
16.45
N/A
EPS
N/A
N/A
Revenue
$35,947,000.00
N/A
Revenue This Year
N/A
$1.65
Revenue Next Year
N/A
$6.42
P/E Ratio
N/A
N/A
Revenue Growth
1.02
N/A
52 Week Low
$1.69
$3.46
52 Week High
$5.17
$4.45

Technical Indicators

Market Signals
Indicator
CCCC
LND
Relative Strength Index (RSI) 43.11 56.80
Support Level $2.10 $3.63
Resistance Level $3.89 $3.81
Average True Range (ATR) 0.37 0.09
MACD -0.10 0.03
Stochastic Oscillator 16.47 71.62

Price Performance

Historical Comparison
CCCC
LND

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patient's lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. The degrader medicines of the company are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT8919, and other discovery products.

About LND Brasilagro Brazilian Agric Real Estate Co Sponsored ADR (Brazil)

Brasilagro - Cia Bras de Prop Agricolas is a Brazil-based company, engaged in the acquisition, development, operation, and sale of rural properties suitable for agricultural activities. The business activity of the firm is operated through Real estate, Grains, Sugarcane, Cattle rising, Cotton, and Other segments. The Grains segment is involved in the production and sale of soybean and corn. The Sugarcane segment includes the sale of raw product. The Real Estate segment presents the P&L from operations carried out in the company's subsidiaries. The Cattle Raising segment consists of producing and selling beef calves after weaning, which characterizes the activity as breeding and the Other segment engages in other corporate activities. The majority of revenue is earned from Grain Segment.

Share on Social Networks: